Frontiers in bioscience (Landmark edition)HumansUrinary Bladder NeoplasmsProto-Oncogene Proteins c-mycPrognosisAnoikis
An Anoikis-Based Prognostic Signature Identifies MYC as a Key Regulator of Malignancy and Immunotherapy Resistance in Bladder Cancer.
Zhen Tang, Jiao Peng, Xiaoyu Pan, Yuefeng Kong, Haisong Lin, Suchun Wei, Yi Zhan, Siping Zeng
Published: 202510.31083/FBL45386
Abstract
BACKGROUND: Resistance to anoikis is a critical mechanism that enables metastatic dissemination. Abrogation of this cellular safeguard is therefore a hallmark of aggressive cancer progression. Despite the importance of anoikis, there are still few bi…
Preview only. Read the full abstract at the source